| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alzheimer’s Association
|
|
|
2006
|
2 |
4 |
p. A11-A16
nvt p.
|
artikel
|
| 2 |
Alzheimer’s Association Medical and Scientific Advisory Council
|
|
|
2006
|
2 |
4 |
p. A6-
1 p.
|
artikel
|
| 3 |
Alzheimer’s Association Update
|
|
|
2006
|
2 |
4 |
p. 334-
1 p.
|
artikel
|
| 4 |
Author Index to Volume 2
|
|
|
2006
|
2 |
4 |
p. 330-331
2 p.
|
artikel
|
| 5 |
Challenges to demonstrating disease-modifying effects in Alzheimer’s disease clinical trials
|
Cummings, Jeffrey L.
|
|
2006
|
2 |
4 |
p. 263-271
9 p.
|
artikel
|
| 6 |
Commentary on “Challenges to demonstrating disease-modifying effects in Alzheimer’s disease clinical trials”
|
Aisen, Paul S.
|
|
2006
|
2 |
4 |
p. 272-274
3 p.
|
artikel
|
| 7 |
Commentary on “Cytoskeletal modulators and pleiotropic strategies for Alzheimer drug discovery.” Atorvastatin’s effect in Alzheimer’s dementia (LEADe) study
|
Hey-Hadavi, Judith
|
|
2006
|
2 |
4 |
p. 282-283
2 p.
|
artikel
|
| 8 |
Commentary on “Cytoskeletal modulators and pleiotropic strategies for Alzheimer drug discovery.” Pleiotropic approaches to Alzheimer’s and other diseases of aging
|
Cole, Greg M.
|
|
2006
|
2 |
4 |
p. 284-286
3 p.
|
artikel
|
| 9 |
Commentary on “Optimal design of clinical trials for drugs designed to slow the course of Alzheimer℉s disease.” Biochemical biomarkers of late-life dementia
|
Clark, Christopher M.
|
|
2006
|
2 |
4 |
p. 287-293
7 p.
|
artikel
|
| 10 |
Commentary on “Perspective on a pathogenesis and treatment of Alzheimer’s disease.” Therapeutic strategies for Alzheimer’s disease: The need for a new era of innovation
|
Smith, Mark A.
|
|
2006
|
2 |
4 |
p. 294-295
2 p.
|
artikel
|
| 11 |
Common threads in neurodegenerative disorders of aging
|
Flint Beal, M.
|
|
2006
|
2 |
4 |
p. 322-326
5 p.
|
artikel
|
| 12 |
Contents
|
|
|
2006
|
2 |
4 |
p. A3-
1 p.
|
artikel
|
| 13 |
Contents
|
|
|
2006
|
2 |
4 |
p. A4-
1 p.
|
artikel
|
| 14 |
Cytoskeletal modulators and pleiotropic strategies for Alzheimer drug discovery
|
Schenk, Dale
|
|
2006
|
2 |
4 |
p. 275-281
7 p.
|
artikel
|
| 15 |
Dementia diagnosis, treatment, and research with American Indians
|
Weiner, Myron F.
|
|
2006
|
2 |
4 |
p. 327-329
3 p.
|
artikel
|
| 16 |
Editorial board
|
|
|
2006
|
2 |
4 |
p. A5-
1 p.
|
artikel
|
| 17 |
Factors associated with use of medications with potential to impair cognition or cholinesterase inhibitors among Alzheimer’s disease patients
|
Huey, Edward D.
|
|
2006
|
2 |
4 |
p. 314-321
8 p.
|
artikel
|
| 18 |
Independent contributions of neural and “higher-order” deficits to symptoms in Alzheimer’s disease: A latent variable modeling approach
|
Tractenberg, Rochelle E.
|
|
2006
|
2 |
4 |
p. 303-313
11 p.
|
artikel
|
| 19 |
Information for Authors
|
|
|
2006
|
2 |
4 |
p. A7-A9
nvt p.
|
artikel
|
| 20 |
Key Word Index to Volume 2
|
|
|
2006
|
2 |
4 |
p. 332-333
2 p.
|
artikel
|
| 21 |
Structural MRI discriminates individuals with Mild Cognitive Impairment from age-matched controls: A combined neuropsychological and voxel based morphometry study
|
Trivedi, Mehul A.
|
|
2006
|
2 |
4 |
p. 296-302
7 p.
|
artikel
|
| 22 |
Subscriber information page
|
|
|
2006
|
2 |
4 |
p. A2-
1 p.
|
artikel
|
Tijdschrift beschrijving